Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypes

BACKGROUND: Although eribulin is used to treat soft tissue sarcomas (STSs), treatment data for rare subtypes are limited. We conducted a post-marketing surveillance study to assess safety and efficacy of eribulin in STS patients stratified by subtype. METHODS: Japanese patients (n = 256) with advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Eisuke, Naito, Yoichi, Asano, Naofumi, Maejima, Aiko, Endo, Makoto, Takahashi, Shunji, Megumi, Yasunori, Kawai, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886464/
https://www.ncbi.nlm.nih.gov/pubmed/31365116
http://dx.doi.org/10.1093/jjco/hyz096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886464/
https://www.ncbi.nlm.nih.gov/pubmed/31365116
http://dx.doi.org/10.1093/jjco/hyz096

Ejemplares similares